Wall Street equity research analysts hold mixed to cautiously optimistic views on Endava stock, with consensus ratings spanning from hold recommendations to selective buy stances. Analysts' 12-month average price targets sit notably higher than its current trading base, though individual outlooks depend heavily on the company's speed of revenue stabilization, digital demand recovery, and margin optimization execution.